期刊文献+

组蛋白去乙酰化酶抑制剂(HDAIs)对异染色质的作用

The effects of histone deacetylase inhibitors on heterochromatin
下载PDF
导出
摘要 组蛋白乙酰化和去乙酰化可调节染色体的多种功能,例如基因表达和染色体分离等。研究发现,组蛋白去乙酰化酶抑制剂(histone deacetylase inhibitors,HDACIs)可诱导分化、生长阻断和肿瘤细胞凋亡,目前HDACIs正作为抗肿瘤药物进行临床试验,在肿瘤治疗中显示出具有较好的应用前景。然而,人们对于HDACIs在生物体内是如何发挥作用以及不同类型细胞为何会有不同的应答途径却关注甚少。本综述通过讨论HDACIs对周期和非周期细胞中组蛋白去乙酰化酶的抑制结果,来阐明组蛋白乙酰化模式的动力学特征,特别是对基因组异染色质的作用。 Histone acetylation and deacetylation can regulate many chromosome functions, such as gene expression and chromosome segregation. Histone deacetylase inhibitors(HDACIs)induce growth arrest, differentiation and apoptosis of cancer cells, and are now undergoing clinical trials as anti-tumor agents and display attractive prospect in cancer therapy. However, little attention has been paid to how HDACIs function in these biological settings and why different cells respond in different ways. In this review, we discussed the consequences of inhibiting histone deacetylases in cycling of histone acetvlation oatterns with a soecific emphasis on heterochromatic regions of the genome.
作者 张伟 明镇寰
出处 《生命科学》 CSCD 2006年第1期80-83,共4页 Chinese Bulletin of Life Sciences
关键词 组蛋白乙酰化和去乙酰化 HDACIs 异染色质 有丝分裂 histone acetylation and deacetylation. HDACIs- heterochromatin mitosis
  • 相关文献

参考文献25

  • 1Jenuwein T, Allis C D. Translating the histone code. Science,2001, 293:1074-1080.
  • 2Taddei A, Roche D, Bickmore W A, et al. The effect of histone deacetylase inhibitors on heterochromatin: implications for anticancer therapy? EMBO Rep, 2005, 6(6): 520-524.
  • 3Glaser K B, Staver M J, Waring J F, et al. Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors:defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines. Mol Cancer Ther,2003, 2 (2): 151-163.
  • 4Marks P A, Richon V M, Miller T, et al. Histone deacetylase inhibitors. Adv Cancer Res, 2004, 91:137-168.
  • 5Maison C, Almouzni G. HP1 and the dynamics of heterochromatin maintenance. Nat Rev Mol Cell Biol, 2004, 5(4):296-304.
  • 6Ekwall K, Olsson T, Turner B M, et al. Transient inhibition of histone deacetylation alters the structural and functional imprint at fission yeast centromeres. Cell, 1997, 91(7):1021 -1032.
  • 7Taddei A, Maison C, Roche D, et al. Reversible disruption of pericentric heterochromatin and centromere function by inhibiting deacetylases. Nat Cell Biol, 2001, 3:114-120.
  • 8Gilchrist S, Gilbert N, Perry P, et al. Nuclear organization of centromeric domains is not perturbed by inhibition of histone deacetylases. Chromosome Res, 2004, 12(5): 505-516.
  • 9de Ruijter A J M, van Gennip A H, Caron H N, et al. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J, 2003, 370:737-749.
  • 10Drummond D C, Noble C O, Kirpotin D B, et al. Clinical development of histone deacetylase inhibitors as anticancer agents. Annu Rev Pharmacol Toxicol, 2005, 45:495-528.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部